We report a case of retroperitoneal teratoma diagnosed prenatally by serial sonographic examinations in the third trimester. A 29-year-old woman was referred for sonographic evaluation at 33 weeks' gestation because of a fetal intra-abdominal mass. Our initial sonographic image suggested a neuroblastoma. Repeat ultrasound images demonstrated an increase in size of the tumor, while the content of the tumor became predominantly solid with areas of calcification. Teratoma should be considered on detection of any cystic or mixed semisolid mass, especially when calcification is present. The fetus was prenatally diagnosed with retroperitoneal teratoma. After birth at 39 weeks, the tumor was removed and histological analysis revealed an immature retroperitoneal teratoma. Intensive monitoring of the changes in ultrasound images of the tumor should provide ground for a precise antenatal diagnosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000201944 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mucinous Cystadenoma Arising in Post-Treatment Non-Seminomatous Germ Cell Tumor: A Rare Occurrence.
Cureus
November 2024
Pathology, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.
Germ cell tumors, the most common of the testicular neoplasms, originate from primordial germ cells. These tumors are known for their totipotent nature, capable of differentiating into various cell types. This case report presents a rare occurrence of mucinous cystadenoma in a patient who received chemotherapy for metastatic left non-seminomatous germ cell tumor (NSGCT) of the testis.
View Article and Find Full Text PDFCase Report: A rare case of antenatally diagnosed mature adrenal teratoma in an infant: insights and literature review.
Front Pediatr
November 2024
Department of Pediatric Surgery, Al-Makassed Islamic Charitable Hospital, Jerusalem, Palestine.
Teratomas are germ cell tumors that arise from the derivatives of the three germ cell layers. They are categorized into subtypes by the extent of maturation, with mature teratomas being the most common subtype. While they can arise in various extragonadal regions, including the retroperitoneum, their occurrence in the retroperitoneal space is extremely rare.
View Article and Find Full Text PDFA predictive system comprising serum microRNAs and radiomics for residual retroperitoneal masses in metastatic nonseminomatous germ cell tumors.
Cell Rep Med
December 2024
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic address:
Predicting the histopathology of residual retroperitoneal masses (RMMs) before post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumors (NSGCTs) can guide individualized treatment and minimize complications. Previous single approach-based models perform poorly in validation. Herein, we introduce a machine learning model that evolves from a single-dimensional tumor diameter to incorporate high-dimensional radiomic features, with its effectiveness assessed using the macro-average area under the receiver operating characteristic curves (AUCs).
View Article and Find Full Text PDFPrimary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour.
BJU Int
December 2024
Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland.
Objectives: To reassess the role of primary retroperitoneal lymph node dissection (RPLND) in patients with marker-negative non-seminomatous germ cell tumour (NSGCT) clinical stage (CS) 2a, to explore results in patients with CS 2b and to evaluate surgical methods, recurrence, and adjuvant chemotherapy indications.
Materials And Methods: Data from 17 institutions were collected, comprising 305 men who underwent primary RPLND for CS 2 NSGCT. Regression analyses were conducted to predict histology in the RPLND specimen and disease-free survival (DFS).
Laparoscopic Retroperitoneal Lymph Node Dissection After Chemotherapy for Nonseminomatous Testicular Germ-Cell Tumor at a Single Center.
Asian J Endosc Surg
November 2024
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Article Synopsis
- - The study examined the outcomes of laparoscopic retroperitoneal lymph node dissection (RPLND) in post-chemotherapy patients with nonseminomatous testicular germ-cell tumors at Kyushu University Hospital between 2016 and 2024.
- - A total of 13 patients participated, with median tumor sizes of 11 mm, and the procedure showed low median blood loss (27 mL) and no severe complications.
- - The results indicate that laparoscopic RPLND is a safe and effective minimally invasive option for selected patients, with no recurrence noted during a median follow-up of 18.6 months.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!